Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells

Immunology

Volumn 122, Issue 1, 2007, Pages 131-139

  Marcilla, Miguel ^a   De Castro, José Antonio López ^a   Castaño, José G ^b   Alvarez, Iñaki ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antigens; Arthritis; Peptides; Proteasome; Salmonella

Indexed keywords

PROTEASOME;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOID CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CELLS, CULTURED; HLA-B27 ANTIGEN; HUMANS; INSULIN; LYMPHOID TISSUE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 34547692601     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02624.x     Document Type: Article

References (36)

1. Ramos M, Alvarez I, Garcia-del-Portillo F, Lopez de Castro JA. Minimal alterations in the HLA-B27-bound peptide repertoire induced upon infection of lymphoid cells with Salmonella typhimurium. Arthritis Rheum 2001 44 : 1677 88.
2. Verjans GM, Ringrose JH, van Alphen L, Feltkamp TE, Kusters JG. Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines. Infect Immun 1994 62 : 2229 35.
3. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973 1 (7809 904 7.
4. Kingsley G, Sieper J. Current perspectives in reactive arthritis. Immunol Today 1993 14 : 387 91.
5. Benjamin R, Parham P. Guilt by association: HLA × B27 and ankylosing spondylitis. Immunol Today 1990 11 : 137 42.
6. Seemuller E, Lupas A, Stock D, Lowe J, Huber R, Baumeister W. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995 268 (5210 579 82.
7. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994 78 : 761 71.
8. Alvarez I, Sesma L, Marcilla M, Ramos M, Marti M, Camafeita E, de Castro JA. Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome. J Biol Chem 2001 276 : 32729 37.
9. Paradela A, Alvarez I, Garcia-Peydro M, Sesma L, Ramos M, Vazquez J, Lopez De Castro JA. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J Immunol 2000 164 : 329 37.
10. Craiu A, Akopian T, Goldberg A, Rock KL. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci USA 1997 94 : 10850 5.
11. Stoltze L, Dick TP, Deeg M, Pommerl B, Rammensee HG, Schild H. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur J Immunol 1998 28 : 4029 36.
12. Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, Drijfhout JW, Neefjes J. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 2004 20 : 495 506.
13. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, Colbert RA. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998 187 : 97 104.
14. Groettrup M, Standera S, Stohwasser R, Kloetzel PM. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci USA 1997 94 : 8970 5.
15. Maksymowych WP, Ikawa T, Yamaguchi A et al. Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27. Infect Immun 1998 66 : 4624 32.
16. Boisgerault F, Mounier J, Tieng V et al. Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri. Infect Immun 1998 66 : 4484 90.
17. Ringrose JH, Yard BA, Muijsers A, Boog CJ, Feltkamp TE. Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells. Clin Rheumatol 1996 15 (Suppl. 1 74 8.
18. Ringrose JH, Meiring HD, Speijer D, Feltkamp TE, van Els CA, de Jong AP, Dankert J. Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire. Infect Immun 2004 72 : 5097 105.
19. Hermann EYuDT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993 342 (8872 646 50.
20. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987 138 : 1657 9.
21. Zemmour J, Little AM, Schendel DJ, Parham P. The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 1992 148 : 1941 8.
22. Calvo V, Rojo S, Lopez D, Galocha B, Lopez de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990 144 : 4038 45.
23. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981 291 (5812 238 9.
24. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978 14 : 9 20.
25. Arribas J, Arizti P, Castano JG. Antibodies against the C2 COOH-terminal region discriminate the active and latent forms of the multicatalytic proteinase complex. J Biol Chem 1994 269 : 12858 64.
26. Arribas J, Castano JG. Kinetic studies of the differential effect of detergents on the peptidase activities of the multicatalytic proteinase from rat liver. J Biol Chem 1990 265 : 13969 73.
27. Ruiz de Mena I, Mahillo E, Arribas J, Castano JG. Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase. Biochem J 1993 296 : 93 7.
28. Marina A, Garcia MA, Albar JP, Yague J, Lopez de Castro JA, Vazquez J. High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry. J Mass Spectrom 1999 34 : 17 27.
29. Yague J, Vazquez J, Lopez de Castro JA. A single amino acid change makes the peptide specificity of B*3910 unrelated to B*3901 and closer to a group of HLA-B proteins including the malaria-protecting allotype HLA-B53. Tissue Antigens 1998 52 : 416 21.
30. Ehring B, Meyer TH, Eckerskorn C, Lottspeich F, Tampe R. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides. Eur J Biochem 1996 235 : 404 15.
31. Dick LR, Moomaw CR, DeMartino GN, Slaughter CA. Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome). Biochemistry 1991 30 : 2725 34.
32. Wenzel T, Eckerskorn C, Lottspeich F, Baumeister W. Existence of a molecular ruler in proteasomes suggested by analysis of degradation products. FEBS Lett 1994 349 : 205 9.
33. Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, Galan JE, Aizawa SI. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 1998 280 (5363 602 5.
34. Galan JE, Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999 284 (5418 1322 8.
35. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998 281 (5376 565 8.
36. Kubori T, Galan JE. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 2003 115 : 333 42.